Rasha Haggag

Rasha Haggag

Auto-generated profile, based on publicly available information

Rasha Haggag

Department of Medical Oncology

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2015 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
AZAbdel Rahman N. Zekri:
Abdel Rahman N. Zekri:
HKHassan Zeinab Korany
Hassan Zeinab Korany
ABAbeer A Bahnassy
Abeer A Bahnassy
HKHussein M Khaled
Hussein M Khaled
MEMahmoud N El-Rouby
Mahmoud N El-Rouby
FAFouad M Abu-Taleb
Fouad M Abu-Taleb
Background: Bladder cancer is one of the most common cancers worldwide. Gene expression profiling using microarray technologies improves the understanding of cancer biology. The aim of this study was to determine the gene expression profile in Egyptian bladder cancer patients. Materials and Methods: Samples from 29 human bladder cancers and adjacent non-neoplastic tissues were analyzed by cDNA microarray, with hierarchical clustering and multidimensional analysis. Results: Five hundred and sixteen genes were differentially expressed of which SOS1, HDAC2, PLXNC1, GTSE1, ULK2, IRS2, ABCA12, TOP3A, HES1, and SRP68 genes were involved in 33 different pathways. The most frequently detected genes were: SOS1 in 20 different pathways; HDAC2 in 5 different pathways; IRS2 in 3 different pathways. There were 388 down-regulated genes. PLCB2 was involved in 11 different pathways, MDM2 in 9 pathways, FZD4 in 5 pathways, p15 and FGF12 in 4 pathways, POLE2 in 3 pathways, and MCM4 and POLR2E in 2 pathways. Thirty genes showed significant differences between transitional cell cancer (TCC) and squamous cell cancer (SCC) samples. Unsupervised cluster analysis of DNA microarray data revealed a clear distinction between low and high grade tumors. In addition 26 genes showed significant differences between low and high tumor stages, including fragile histidine triad, Ras and sialyltransferase 8 (alpha) and 16 showed significant differences between low and high tumor grades, like methionine adenosyl transferase II, beta. Conclusions: The present study identified some genes, that can be used as molecular biomarkers or target genes in Egyptian bladder cancer patients.

24 March 2020 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
SSShereen El Shorbagy
Shereen El Shorbagy
FAFouad Abutaleb
Fouad Abutaleb
HLHany A. Labib
Hany A. Labib
HEHuda Ebian
Huda Ebian
OHOla A. Harb
Ola A. Harb
RHRasha Haggag
Rasha Haggag

15 July 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SEShereef Ahmed Elsamany
Shereef Ahmed Elsamany
AAAbdullah Saeed Alzahrani
Abdullah Saeed Alzahrani
MMMervat Mahrous Mohamed
Mervat Mahrous Mohamed
SESoha Ali Elmorsy
Soha Ali Elmorsy
JZJamal Eddin Zekri
Jamal Eddin Zekri
HTHani Abdalla El Taani
Hani Abdalla El Taani
Clinico-Pathological Patterns and Survival Outcome of Colorectal Cancer in Young Patients: Western Saudi Arabia Experience Young patients;colorectal cancer;clinicopathological;survival;Saudi Arabia; Background: The prognosis of young colorectal cancer (CRC) patients has been addressed by several studies but with contradictory results. The aim of the present study was to evaluate the clinico-pathological features of young Saudi patients with CRC in addition to displaying their survival outcome. Materials and Methods: In this retrospective study, young CRC patients (${\leq}40$ years) diagnosed between 2007 and 2011 from 4 centres in western Saudi Arabia, were included. Clinico-pathological features, tumor markers, dates of disease relapse and death were collected. Survival parameters were compared with those of older Saudi patients, reported in previous studies. Results: One hundred and sixteen young patients with CRC were identified (32.2% rectal, 67.8% colon). Some 44% were metastatic while 32.7% had stage III at diagnosis. Patients with grade 3 tumors made up 29.4% of the total while 49.5% had positive lymphovascular invasion (LVI), 56% had a lymph node (LN) ratio ${\geq}0.2$ and 40.2% were K-ras mutant. Median disease-free survival (DFS) and overall survival (OS) in non-metastatic cases were 22.8 and 49.6 months respectively with better median DFS in K-ras wild compared to mutant patients (28.5 vs 20.9 months, p=0.005). In metastatic cases, median OS was 19.5 months. These survival outcomes are inferior compared to those of older Saudi patients reported in prior studies. Conclusions: Young CRC patients present more commonly with advanced stage and a high incidence of adverse prognostic factors such as LVI and high LN ratio. Young CRC patients seem to have worse survival compared to older Saudi patients.

1 March 2017 in Journal of Advanced Research
Verified
Journal Article
Open access
HKHussein Khaled
Hussein Khaled
FAFouad Abu-Taleb
Fouad Abu-Taleb
RHRasha Haggag
Rasha Haggag
B-cell NHL is strongly associated with HCV that was proved in the last 2 decades. The most common HCV infection related B-NHL subtypes include MZL and DLBCL lymphomas. HCV-positive NHL patients usually present with older age at diagnosis, higher LDH, and more extranodal disease. The standard chemo-immunotherapy tolerance is generally good. Antiviral treatment achieves virological and hematological remission in HCV associated indolent lymphoma. More aggressive lymphoma requires combination of antiviral treatment and chemotherapy. New generation of HCV antiviral drugs is safe and is highly efficacious. Regimens including DAAs appear promising options as they can reduce the HCV-associated NHL incidence by dramatically lowering the HCV chronic carriers.

12 December 2013 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
RHRasha Haggag
Rasha Haggag
KFKamel Farag
Kamel Farag
FAFouad Abu-Taleb
Fouad Abu-Taleb
SSSameh Shamaa
Sameh Shamaa
AZAbdel Rahman N. Zekri:
Abdel Rahman N. Zekri:
HKHussein Khaled
Hussein Khaled

28 February 2012 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
PDF file
AAAbdullah S. Al-Zahrani
Abdullah S. Al-Zahrani
AEAmr T. El-Kashif
Amr T. El-Kashif
RHRasha M. Haggag
Rasha M. Haggag
SASamy A. Alsirafy
Samy A. Alsirafy
The medical records of deceased patients were reviewed to describe the pattern of cancer deaths in a newly established Saudi tertiary care hospital. During eleven months, 87 patients died of cancer. The majority (80 patients, 92%) died of incurable cancer; among which 53% did not receive any systemic anti-cancer therapy (SAT) and 43% received SAT with palliative intent. Younger age (< 65 years), relatively chemosensitive tumours and initial presentation in a potentially curable stage were associated with higher prevalence of palliative SAT administration (p = 0.009, 0.019 and 0.001, respectively). The last palliative SAT was administered during the last two months of life in 66% and during the last two weeks in 14%. During the last admission, 54% of patients were admitted through emergency room, 50% stayed >14 days and 14% died in intensive care unit or emergency room. The results demonstrate that palliative care is a realistic treatment for the majority of patients in our setting and that a significant proportion of these patients receive aggressive care at the end-of-life. There is a need to establish an integrative palliative care program to improve the quality-of-life of dying cancer patients in our region and to minimize the aggressiveness of end-of-life care.